Download PDF
Thromb Haemost 2001; 85(03): 552-559
DOI: 10.1055/s-0037-1615620
Review Article
Schattauer GmbH

The Subendothelium of the HMEC-1 Cell Line Supports Thrombus Formation in the Absence of von Willebrand Factor and Collagen Types I, III and VI

Arnaud Bonnefoy
1   Laboratoire “Protéines Adhésives et Protéases des Cellules Vasculaires et Sanguines”, Unité 353 INSERM, Institut d’Hématologie, Université Paris VII Denis-Diderot, Hôpital St Louis, Paris, France; Department of Clinical Biochemistry and Molecular Pathology
,
Jolan Harsfalvi
1   Laboratoire “Protéines Adhésives et Protéases des Cellules Vasculaires et Sanguines”, Unité 353 INSERM, Institut d’Hématologie, Université Paris VII Denis-Diderot, Hôpital St Louis, Paris, France; Department of Clinical Biochemistry and Molecular Pathology
,
George Pfliegler
2   2nd Department of Medicine, University of Debrecen, Debrecen, Hungary
,
Françoise Fauvel-Lafève
1   Laboratoire “Protéines Adhésives et Protéases des Cellules Vasculaires et Sanguines”, Unité 353 INSERM, Institut d’Hématologie, Université Paris VII Denis-Diderot, Hôpital St Louis, Paris, France; Department of Clinical Biochemistry and Molecular Pathology
,
Chantal Legrand
1   Laboratoire “Protéines Adhésives et Protéases des Cellules Vasculaires et Sanguines”, Unité 353 INSERM, Institut d’Hématologie, Université Paris VII Denis-Diderot, Hôpital St Louis, Paris, France; Department of Clinical Biochemistry and Molecular Pathology
› Author Affiliations
Further Information

Publication History

Received 14 December 1999

Accepted after resubmission 23 May 2000

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

Summary

The macromolecular composition of the extracellular matrix (ECM) produced by the human microvascular endothelial cell line (HMEC-1) was determined by ELISA and its thrombogenicity was studied in blood perfusion assays. Results were compared with those obtained with the ECM produced by human umbilical vein endothelial cells (HUVEC). The HMEC-1’s ECM contains collagen type IV, fibronectin, laminin and thrombospondin, but no detectable levels of collagen types I, III and VI, or von Willebrand factor (vWF), whereas all these components were found in the ECM synthesized by HUVEC. HMEC-1’s ECM was perfused with low-molecular-weight heparin-anticoagulated blood at two wall shear rates (650/s and 2600/s), representative of moderate and high arterial wall shear rates, in parallel plate flow chambers for 5 min. This resulted in the formation of large platelet aggregates, compared to essentially a monolayer of adherent platelets on HUVEC’s ECM. Interestingly, large thrombi were formed at 2600/s when HMEC-1’s ECM was perfused with the blood of a patient with severe type III von Willebrand disease lacking both plasma and platelet vWF, indicating that vWF was not absolutely required for thrombus formation on this matrix. Thrombin generated on the HMEC-1’s ECM contributed importantly to the large platelet thrombi formed, shown by performing blood perfusion experiments in the presence of thrombin inhibitors. Our results indicate that 1) platelet adhesion and aggregate formation on a subendothelium may occur at a high shear rate (2600/s) without the participation of collagen types I, III and VI, and vWF; and 2) the HMEC-1 cell line may prove useful for in vitro studies of the thrombogenic properties of microvascular subendothelium which in most cases does not contain fibrillar collagens and vWF.

Keywords

Thrombus formation - von Willebrand factor - collagen - HMEC-1 - shear rate - extracellular matrix (ECM)
 

  • References

  • 1 Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII/vWF bound to subendothelium. Nature (Lond.) 1979; 279: 636-8.
    CrossrefPubMedGoogle Scholar
  • 2 Nievelstein FEM, de Groot PG, D’Alessio P, Heijnen HFG, Orlando E, Sixma JJ. Platelet adhesion to vascular cells. The role of exogenous von Willebrand factor in platelet adhesion. Arteriosclerosis 1990; 10: 462-9.
    CrossrefPubMedGoogle Scholar
  • 3 Zwaginga JJ, Sixma JJ, de Groot PG. Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant. Arteriosclerosis 1990; 10: 49-61.
    CrossrefPubMedGoogle Scholar
  • 4 Turitto VT, Weiss HJ, Baumgartner HR. Platelet interaction with rabbit subendothelium in von Willebrand’s disease: altered thrombus formation distinct from defective platelet adhesion. J Clin Invest 1984; 74: 1730-41.
    CrossrefPubMedGoogle Scholar
  • 5 Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-74.
    PubMedGoogle Scholar
  • 6 Fressinaud E, Sakariassen KS, Rothschild C, Baumgartner HR, Meyer D. Shear rate-dependent impairment of thrombus growth on collagen in non-anticoagulated blood from patients with von Willebrand disease and hemophilia A. Blood 1992; 80: 988-94.
    PubMedGoogle Scholar
  • 7 Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999; 87: 1234-40.
    PubMedGoogle Scholar
  • 8 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
    CrossrefPubMedGoogle Scholar
  • 9 Sixma JJ, van Zauten GH, Saelman EU, Verkleij M, Lankhof H, Nieuwenhuis HH, de Groot PG. Platelet adhesion to collagen. Thromb Haemost 1995; 74: 454-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Legrand YJ, Rodriguez-Zeballos A, Kartali G, Fauvel F, Caen JP. Adsorption of factor VIII antigen-activity complex by collagen. Thromb Res 1978; 13: 909-11.
    CrossrefPubMedGoogle Scholar
  • 11 Cruz MA, Yuan H, Lee JR, Wise RJ, Handin RI. Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant v WFA domain polypeptides. J Biol Chem 1995; 270: 10822-7.
    CrossrefPubMedGoogle Scholar
  • 12 Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, Vink T, de Groot PG, Sixma JJ. A3 domain is essential for interation of von Willebrand factor with collagen type III. Thromb Haemost 1996; 75: 950-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Rand JH, Patel ND, Schwartz E, Zhou S-L, Potter BJ. 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 1988; 88: 253-9.
    PubMedGoogle Scholar
  • 14 Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J. von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochem J 1997; 324: 185-91.
    CrossrefPubMedGoogle Scholar
  • 15 Van Zanten GH, Saelman EUM, Schut-Hese KM, Wu YP, Slootweg PJ, Nieuwenhuis HK, de Groot PG, Sixma JJ. Platelet adhesion to collagen type IV under flow conditions. Blood 1996; 88: 3862-71.
    PubMedGoogle Scholar
  • 16 Houdijk WP, Sakariassen KS, Nievelstein PF, Sixma JJ. Role of Factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagens types I and III. J Clin Invest 1985; 75: 531-40.
    CrossrefPubMedGoogle Scholar
  • 17 Bastida E, Escolar G, Ordinas A, Sixma JJ. Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces. Blood 1987; 70: 1437-42.
    PubMedGoogle Scholar
  • 18 Hindriks G, Ijsseldijk MJ, Sonnenberg A, Sixma JJ, de Groot PG. Platelet adhesion to laminin: role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. Blood 1992; 79: 928-35.
    PubMedGoogle Scholar
  • 19 Agbanyo FR, Sixma JJ, de Groot P, Languino LR, Plow EF. Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 1993; 92: 288-96.
    CrossrefPubMedGoogle Scholar
  • 20 Sakariassen KS, Baumgartner HR. Axial dependence of platelet-collagen interactions in flowing blood. Upstream thrombus growth impairs downstream platelet adhesion. Arteriosclerosis 1989; 9: 33-42.
    CrossrefPubMedGoogle Scholar
  • 21 Frojmovic MM, Kasirer-Friede A, Goldsmith HL, Brown EA. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa. Thromb Haemost 1997; 7: 568-76.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 André P, Brouland JP, Roussi J, Bonneau M, Pignaud G, Bal dit Sollier C, Hainaud P, Vaiman M, Drouet L. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig. Exp Hematol 1998; 26: 620-6.
    PubMedGoogle Scholar
  • 23 Legrand C, Thibert V, Dubernard V, Bégault B, Lawler J. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets. Modulation of platelet aggregation. Blood 1992; 79: 1995-2003.
    PubMedGoogle Scholar
  • 24 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-56.
    CrossrefPubMedGoogle Scholar
  • 25 Tannenbaum SH, Rick ME, Shafer B, Gralnick HR. Subendothelial matrix of cultured endothelial cells contains fully processed high molecular weight von Willebrand factor. J Lab Clin Med 1989; 113: 372-8.
    PubMedGoogle Scholar
  • 26 Myers JC, Howard PS, Walther SE, Gorfien SF, Macarak EJ. Collagen and fibronectin gene expression in cultured endothelial cells. Ann NY Acad Sci 1990; 580: 120-31.
    CrossrefPubMedGoogle Scholar
  • 27 Gerritsen ME. Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol 1987; 36: 2701-11.
    CrossrefPubMedGoogle Scholar
  • 28 Wu QY, Drouet L, Carrier JL, Rotschild C, Berard M, Rouault C, Caen JP, Meyer D. Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis 1987; 7: 47-54.
    CrossrefPubMedGoogle Scholar
  • 29 Rand JH, Badimon L, Gordon RE, Uson RR, Fuster V. Distribution of von Willebrand factor in porcine intima varies with blood vessel type and location. Arteriosclerosis 1987; 7: 287-91.
    CrossrefPubMedGoogle Scholar
  • 30 Yamamoto K, de Waard V, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. Blood 1998; 92: 2791-801.
    PubMedGoogle Scholar
  • 31 Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990; 4: 1577-90.
    CrossrefPubMedGoogle Scholar
  • 32 Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683-90.
    CrossrefPubMedGoogle Scholar
  • 33 Xu Y, Swerlick RA, Sepp N, Bosse D, Ades EW, Lawley TJ. Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol 1994; 102: 833-7.
    CrossrefPubMedGoogle Scholar
  • 34 Ribeiro MJA, Phillips DJ, Benson JM, Evatt BL, Ades EW, Hooper WC. Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). Thromb Res 1995; 79: 153-61.
    CrossrefPubMedGoogle Scholar
  • 35 Dubernard V, Legrand C. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton. J Lab Clin Med 1991; 118: 446-57.
    PubMedGoogle Scholar
  • 36 Legrand C, Dubernard V, Kieffer N, Nurden AT. Use of a monoclonal antibody to measure the surface expression of thrombospondin following platelet activation. Eur J. Biochem 1988; 171: 393-9.
    CrossrefPubMedGoogle Scholar
  • 37 Morandi V, Lamhamedi S, Lambert S, Fauvel-Lafeve F, Legrand Y, Legrand C. Proinflammatory cytokines (interleukin-1 and tumor necrosis factor α down regulate synthesis and secretion of thrombospondin by human endothelial cells. J Cell Physiol 1994; 160: 367-77.
    CrossrefPubMedGoogle Scholar
  • 38 De Groot PG, Reinders JH, Sixma JJ. Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets. J Cell Biol 1987; 104: 697-704.
    CrossrefPubMedGoogle Scholar
  • 39 Boda Z, Pfliegler G, Harsfalvi J, Rak K. Treatment of the severe bleeding episode in type III von Willebrand’s disease by simultaneous administration of cryoprecipitate and platelet concentrate. Blood Coag Fibrinol 1991; 2: 775-7.
    CrossrefPubMedGoogle Scholar
  • 40 Sakariassen KS, Aarts PAMM, de Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983; 102: 522-35.
    PubMedGoogle Scholar
  • 41 Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-5.
    CrossrefPubMedGoogle Scholar
  • 42 Fenton JWD, Villanueva GB, Ofosu FA, Maraganore JM. Thrombin inhibition by hirudin: how hirudin inhibits thrombin. Haemostasis 1991; 1: 27-31.
    PubMedGoogle Scholar
  • 43 Sakariassen KS, Banga JD, de Groot PG, Sixma JJ. Comparison of platelet interaction with subendothelium of human and renal arteries and the extracellular matrix produced by human venous endothelial cells. Thromb Haemost 1984; 52: 60-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Zwaginga JJ, de Boer HC, Ijsseldijk MJW, Kerkhof A, Muller-Berghaus G, Gruhlichhenn J, Sixma JJ, de Groot PG. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Arteriosclerosis 1990; 10: 437-48.
    CrossrefPubMedGoogle Scholar
  • 45 De Groot PG, Ottenhof-Rovers M, van Mourik JA, Sixma JJ. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen. J Clin Invest 1988; 82: 65-73.
    CrossrefPubMedGoogle Scholar
  • 46 Baruch D, Denis C, Marteaux C, Schoevaert D, Coulombel L, Meyer D. Role of von Willebrand factor associated to extracellular matrices in platelet adhesion. Blood 1991; 77: 519-27.
    PubMedGoogle Scholar
  • 47 Tseng SCG, Savion N, Gospodarowicz D, Stern R. Characterization of collagens synthesized by cultured bovine corneal endothelial cells. J Biol Chem 1981; 256: 3361-5.
    PubMedGoogle Scholar
  • 48 Vlodavsky I, Eldor A, Hyam E, Atzmon R, Fuks Z. Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. Thromb Res 1982; 28: 179-91.
    CrossrefPubMedGoogle Scholar
  • 49 Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85: 283-94.
    CrossrefPubMedGoogle Scholar
  • 50 Diquélou A, Lemozy S, Dupouy D, Boneu B, Sakariassen K, Cadroy Y. Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface. Blood 1994; 84: 2206-13.
    PubMedGoogle Scholar
  • 51 Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385-92.
    CrossrefPubMedGoogle Scholar